Standard-dose epirubicin increases the pathological complete response rate in neoadjuvant chemotherapy for breast cancer: a multicenter retrospective study

BACKGROUND: Neoadjuvant chemotherapy (NAC) has become the best comprehensive treatment choice for breast cancer. Epirubicin is a crucial drug widely used in breast cancer chemotherapy, but it is often used with a reduced dosage in NAC for Chinese patients for its notable cardiotoxicity and frequent...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Gland Surg
Main Authors: Shan, Ben-Jie, Shen, Xia-Bo, Jin, Wei, Dong, Meng-Hao, Han, Xing-Hua, Lin, Lin, Chen, Jian, Huang, Da-Bing, Qian, Jun, Zhang, Jing-Jie, Pan, Yue-Yin
Formato: Artigo
Idioma:Inglês
Publicado: AME Publishing Company 2020
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7475373/
https://ncbi.nlm.nih.gov/pubmed/32953611
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/gs-20-647
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares